
Boston Scientific Corporation BSX
Annual report 2025
added 02-17-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.48 B |
Market Cap[1] |
$ 88.7 B |
EBITDA (LTM) |
$ 4.18 B |
P/E (LTM) |
32.76 |
P/S (LTM) |
4.67 |
EPS (LTM) |
1.83 |
Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.
Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.
The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.
The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 13.08 | 2.19 % | $ 1.77 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | -2.58 % | $ 38 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.22 | - | $ 121 M | Nasdaq Global Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.21 | -4.84 % | $ 317 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 93.7 | -1.24 % | $ 12.7 B | NYSE,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Electromed
ELMD
|
$ 26.0 | -1.48 % | $ 220 M | NYSE American | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.12 | -1.85 % | $ 1.29 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 5.48 | 2.81 % | $ 1.16 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.82 | -2.29 % | $ 371 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 10.84 | - | $ 388 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 63.41 | -1.23 % | $ 3.46 B | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.08 | 1.89 % | $ 18.3 M | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.21 | 2.36 % | $ 62.3 M | Nasdaq Capital Market | ||
|
CONMED Corporation
CNMD
|
$ 37.87 | -1.23 % | $ 1.18 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 55.07 | -2.2 % | $ 1.62 B | NYSE,SPB | ||
|
Pulmonx Corporation
LUNG
|
$ 1.28 | 0.79 % | $ 52.1 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.35 | -0.78 % | $ 2.96 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 83.46 | -0.94 % | $ 48.8 B | NYSE,SPB | ||
|
MiMedx Group
MDXG
|
$ 3.34 | -2.62 % | $ 494 M | Nasdaq Global Select Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Myomo
MYO
|
$ 0.83 | 0.8 % | $ 34.7 M | NYSE American | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Orthofix Medical
OFIX
|
$ 12.32 | -0.24 % | $ 488 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.